Codexis Inc (CDXS)

NASDAQ

$2.21

Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.

Sector:

Industry:

68 analysts

Buy

Target: $6.58 (+197.74%)

Market Cap

$201M

Free Cash Flow Yield

-11.01%

Beta (5Y)

1.82

Adjust inflation

Log

Valuation

Market Cap$201M

Forward P/E149.25

PEG13.53

P/S2.48

P/B4.73

Profitability

Total Revenue (TTM)$78M

Gross Profit (TTM)$19M

EBITDA-$24M

Profit Margin-57.1%

Operating Margin-52.7%

EPS-$0.35

Financial Health

Debt-to-Equity93.6%

Free Cash Flow Yield-11.01%

Growth & Risk

EPS 5Y CAGR-2.98%

Revenue 5Y CAGR+1.52%

FCF 5Y CAGR-3.92%

Beta (5Y)1.82

Sharpe Ratio0.02